Champions Oncology, Inc.
- CSBR
- NASDAQ
- Biotechnology
- Oncology Precision Medicine
- Tumor Modeling (PDX)
$4.69
Today −0.21%Quote Oct 19, 2026, 08:00 PM UTC
−11.51%over the last month
Max drawdown −11.5%From 1-month high −11.5%3 months −23.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Champions Oncology
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States.
Where the money comes from
Q1 2027 revenue $15.2M
- Pharmacology Services$14.2M92.9%
- Product and Service, Other$183,0001.2%
- Other / not reported$893,0005.9%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
214
Market value
$65.3M
Quote Oct 19
Analyst target
$12.00
+155.9% from here
Floor
$4.61
1.7% below price
Resistance
$4.75
1.3% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CSBRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free